NCCN Guidelines Insights: Soft tissue sarcoma, version 1.2021 Guidelines


Authors: von Mehren, M.; Kane, J. M. 3rd; Bui, M. M.; Choy, E.; Connelly, M.; Dry, S.; Ganjoo, K. N.; George, S.; Gonzalez, R. J.; Heslin, M. J.; Homsi, J.; Keedy, V.; Kelly, C. M.; Kim, E.; Liebner, D.; McCarter, M.; McGarry, S. V.; Meyer, C.; Pappo, A. S.; Parkes, A. M.; Paz, I. B.; Petersen, I. A.; Poppe, M.; Riedel, R. F.; Rubin, B.; Schuetze, S.; Shabason, J.; Sicklick, J. K.; Spraker, M. B.; Zimel, M.; Bergman, M. A.; George, G. V.
Title: NCCN Guidelines Insights: Soft tissue sarcoma, version 1.2021
Abstract: The NCCN Guidelines for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with soft tissue sarcomas. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including the development of a separate and distinct guideline for gastrointestinal stromal tumors (GISTs); reconception of the management of desmoid tumors; inclusion of further recommendations for the diagnosis and management of extremity/body wall, head/neck sarcomas, and retroperitoneal sarcomas; modification and addition of systemic therapy regimens for sarcoma subtypes; and revision of the principles of radiation therapy for soft tissue sarcomas.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 18
Issue: 12
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2020-12-01
Start Page: 1604
End Page: 1612
Language: English
DOI: 10.6004/jnccn.2020.0058
PUBMED: 33285515
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 4 January 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ciara Marie Kelly
    89 Kelly
Related MSK Work